Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine

Neurological Sciences

Volumn 27, Issue 3, 2006, Pages 173-175

  Albani, Fiorenzo ^a   Baruzzi, A ^a   Antonini, L ^b   De Maria, G ^b   Avanzini, G ^b   Basso, P ^b   Bettini, B ^b   Benna, P ^b   Bisulli, F ^b   Consoli, D ^b   D'Alessandro, P ^b   Garofalo, P ^b   Murri, L ^b   Nuscas, G ^b   Musumeci, S ^b   Paggi, A ^b   Passarella, B ^b   Striano, S ^b   Zucca, C ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Carbamazepine; Epilepsy; Long term efficacy; Oxcarbazepine; Switch

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CLINICAL TRIALS; DRUG RESISTANCE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME; TREATMENT OUTCOME;

EID: 33746691206     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0663-2     Document Type: Article

References (8)

1. Bang LM, Goa KL (2004) Spotlight on oxcarbazepine in epilepsy. CNS Drugs 18:57-61
2. Van Parys JA, Meinardi H (1994) Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a namedpatient basis. Epilepsy Res 19:79-85
3. Beydoun A, Sachdeo RC, Kutluay et al (2003) Sustained efficacy and long-term safety of oxcarbazepine: One-year open-label extension of a study in refractory partial epilepsy. Epilepsia 44:1160-1165
4. Friis ML, Kristensen O, Boas J et al (1993) Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87:224-227
5. Rainesalo S, Peltola J, Auvinen A, Keranen T (2005) Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics. Seizure 14:72-74
6. Albani F, Grassi B, Ferrara R et al and The PRIMO Study Group (2004) Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure 13:254-263
7. Striano S, Striano P, Di Nocera P et al (2006) Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. Epilepsy Res 69:170-176
8. Schmidt D, Arroyo S, Baulac M et al (2001) Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: A consensus view. Acta Neurol Scand 104:167-170